share_log

Takeda Pharmaceutical | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Takeda Pharmaceutical Company Limited(12.2%),Takeda Pharmaceuticals U.S.A., Inc(9.8%)

武田製藥 | SC 13G/A:超過5%持股股東披露文件(修正)-Takeda Pharmaceutical Company Limited(12.2%),Takeda Pharmaceuticals U.S.A., Inc(9.8%)

美股SEC公告 ·  2023/02/04 00:48
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息